Cargando…

Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda - a descriptive study

BACKGROUND: Following initiation of MDR-TB treatment, patients have a choice to receive follow up DOT supervision at either the central initiating facility or at a peripheral facility. OBJECTIVES: We describe the adherence patterns of MDR-TB patients undergoing DOT supervision at the two health faci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukasa, Joseph, Kayongo, Edward, Kawooya, Ismael, Lukoye, Deus, Etwom, Alfred, Mugabe, Frank, Tweya, Hannock, Izizinga, Rose, Mijumbi-Deve, Rhona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609083/ https://www.ncbi.nlm.nih.gov/pubmed/33163023 http://dx.doi.org/10.4314/ahs.v20i2.10

Ejemplares similares

Pre-diagnostic drop out of presumptive TB patients and its associated factors at Bugembe Health Centre IV in Jinja, Uganda
por: Ekuka, Godfrey, et al.
Publicado: (2020)

Paper 1: Demand-driven rapid reviews for health policy and systems decision-making: lessons from Lebanon, Ethiopia, and South Africa on researchers and policymakers’ experiences
por: Mijumbi-Deve, Rhona M., et al.
Publicado: (2022)

Vulnerability of populations to malaria after indoor residual spraying is withdrawn from areas where its use has previously been sustained: a protocol for a systematic review
por: Orishaba, Philip, et al.
Publicado: (2022)

A Process Evaluation to Assess Contextual Factors Associated With the Uptake of a Rapid Response Service to Support Health Systems’ Decision-Making in Uganda
por: Mijumbi-Deve, Rhona, et al.
Publicado: (2017)

Policymaker experiences with rapid response briefs to address health-system and technology questions in Uganda
por: Mijumbi-Deve, Rhona, et al.
Publicado: (2017)

Trend and outcome of notified children with tuberculosis during 2011-2015 in Kampala, Uganda
por: Wobudeya, Eric, et al.
Publicado: (2017)

Improving institutional platforms for evidence-informed decision-making: getting beyond technical solutions
por: Mecaskey, Jeffrey, et al.
Publicado: (2023)

High rates of culture conversion and low loss to follow-up in MDR-TB patients managed at Regional Referral Hospitals in Uganda
por: Martin, Mbonye Kayitale, et al.
Publicado: (2021)

The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB
por: Cadosch, Dominique, et al.
Publicado: (2016)

Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009–2010; a retrospective cross-sectional study
por: Wobudeya, Eric, et al.
Publicado: (2015)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)
por: Kateete, David Patrick, et al.
Publicado: (2019)

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
por: Albert, Heidi, et al.
Publicado: (2010)

Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients
por: Van der Walt, Martha, et al.
Publicado: (2013)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda
por: Batte, Charles, et al.
Publicado: (2021)

Beyond the metrics of health research performance in African countries
por: Mijumbi-Deve, Rhona, et al.
Publicado: (2021)

Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
por: Tabatabai, Julia, et al.
Publicado: (2014)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

1661. The association of spirometric impairment and history of TB: a population based study in Uganda
por: Robertson, Nicole M, et al.
Publicado: (2020)

Measuring health science research and development in Africa: mapping the available data
por: Wenham, Clare, et al.
Publicado: (2021)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)

Patient attitudes towards community-based tuberculosis DOT and adherence to treatment in an urban setting; Kampala, Uganda
por: Hassard, Sempeera, et al.
Publicado: (2017)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB
por: Bishai, Jason D., et al.
Publicado: (2010)

The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

Direct Nitrate Reductase Assay versus Microscopic Observation Drug Susceptibility Test for Rapid Detection of MDR-TB in Uganda
por: Bwanga, Freddie, et al.
Publicado: (2011)

Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda
por: Komakech, Kevin, et al.
Publicado: (2023)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Uptake of evidence in policy development: the case of user fees for health care in public health facilities in Uganda
por: Nabyonga-Orem, Juliet, et al.
Publicado: (2014)

Why has MDR-TB prevalence increased in Iran?
por: Heidary, Mohsen, et al.
Publicado: (2016)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
por: Kundu, Debashish, et al.
Publicado: (2018)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

759. Molecular Characterization and Epidemiology of Multidrug-Resistant Mycobacterium tuberculosis (MDR-TB) and Identification of Possible Cases of Local Transmission of MDR-TB in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2018)

Uganda Public Health Fellowship Program's Contributions to the National HIV and TB Programs, 2015–2020
por: Ario, Alex R., et al.
Publicado: (2022)

Correction: The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vgr6c10u52t66i1ufghq4k3rk2